TracheostomyIZ-TRACHNCT07404592
Tracheostomy Practices in Adult Intensive Care Units: A Multicenter Point-Prevalence Study in Izmir (IZ-TRACH)
An observational study of Tracheostomy, run by Izmir City Hospital at 1 site in Turkey (Türkiye).
Trial summary
This completed observational study describes physician-reported reasons for postponement among adults with an established tracheostomy who were present in participating intensive care units (ICUs) on a single survey day. Read more about this study
- Who is it for?
- Ages 18 years and older
- Conditions the study is for
- Tracheostomy
- What is being tested?
- Tracheostomy
- Type of treatment
- Surgery or procedure
- How many people
- 282 participants
- Where
- 1 siteTurkey (Türkiye)
- Study dates
- 8 Sep 2025to 8 Oct 2025
- How long will I take part?
- 30 Days
- Phase
- Observational
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 years and older
- All sexes
- No healthy volunteers
- Adult, Older adult
Study population: Adults aged 18 years or older present in eleven participating adult ICUs across six hospitals in Izmir, Turkey, on 8 September 2025 formed the 282-person census. Forty-six had a surgical or percutaneous tracheostomy and contribute to overall prevalence. The main descriptive sample includes the 42 whose tracheostomy was established during the current admission. Four with tracheostomies created before admission are included only in census/prevalence counts and exclusion accounting. This revision of the analysis population does not change the census eligibility criteria or actual enrollment of 282.
Who may be able to join
- Aged 18 years and older
- Present in a participating adult ICU on the point-prevalence day
Who cannot join
- Patients younger than 18 years
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Tracheostomy Practices in Adult Intensive Care Units in Izmir, Turkey: A Multicenter Point-Prevalence Study
This completed observational study describes physician-reported reasons for postponement among adults with an established tracheostomy who were present in participating intensive care units (ICUs) on a single survey day. The survey was conducted in eleven adult ICUs in six hospitals in Izmir, Turkey, on 8 September 2025. The census comprised 282 adults; 46 had a tracheostomy. All 46 contribute to the prevalence numerator. The main descriptive sample comprises 42 patients whose tracheostomy was established during the current admission; four patients with tracheostomies created before admission are excluded from patient-level clinical and outcome summaries. Previous clinical and procedural information was collected retrospectively, and postponement reasons were obtained from primary treating physicians. Mortality was assessed 30 days after the index day, on 8 October 2025. Analyses describe reason categories, total intubation-to-tracheostomy intervals, patient and procedural characteristics, recorded complications, and post-index in-hospital mortality. They cannot establish the duration attributable to family decision-making, preventability of postponement, or effects on outcomes. Registration and this clarification occurred after study completion; no prospective specification of the revised analyses is claimed.
Read the detailed description
Design and populations
This was a multicenter point-prevalence survey on 8 September 2025 with a subsequent assessment of recorded in-hospital mortality on 8 October 2025. The census included 282 adults present in eleven participating ICUs across six hospitals. Forty-six had an established tracheostomy and contribute to the point-prevalence numerator. The main descriptive sample comprises 42 patients whose tracheostomy was established during the current admission. Four with pre-admission tracheostomies remain in the census and prevalence counts but are excluded from the main patient-level summaries. Patients who died or left the ICU before the index day and patients who had not undergone tracheostomy by that date are absent from this sample.
Data collection and compilation
The initial compilation contained 30 tracheostomy patients from seven ICUs. Records for another 16 patients from four additional ICUs within one participating hospital were subsequently incorporated, yielding 46 tracheostomy patients across eleven ICUs. Their postponement reports were obtained on the same index day, 8 September 2025; the records were merged later. Of these 16 patients, three had pre-admission tracheostomies. The remaining 13 contributed to the main analysis, and four had a family-related reason.
Six hospital contact physicians submitted the online forms using information from eleven primary treating physicians, one for each ICU. At the hospital comprising six ICUs, the contact physician collated information from all six primary physicians, including the contact physician's own ICU. Each of the other five hospitals contributed one ICU. Participation in the original tracheostomy decision was not recorded, and reports may have concerned decisions made by colleagues.
Physician-reported reasons and intervals
The index-day form asked: "Please specify any factors that caused tracheostomy to be performed late." Examples included high-dose inotropic support and lack of consent from relatives. This wording assumed lateness and may have influenced responses. Fourteen patients had an explicit "No documented delay" response; none of the 42 responses was blank. These patients are described as having no reported postponement reason, which does not independently establish absence of postponement. Other recorded categories were a family-related reason, hemodynamic instability, awaiting surgical eligibility and bleeding diathesis. Multiple reasons and an "Other" free-text option were allowed; neither was used. Investigators did not select a predominant reason from multiple responses.
A family-related reason represents the physician's account of deliberation or agreement involving relatives or a surrogate decision-maker, not a demonstrated avoidable delay. The measured interval is total time from intubation to tracheostomy. Intended procedure dates, recommendation dates, discussion/agreement dates and clinical readiness dates were unavailable, so time attributable to an individual reason cannot be calculated.
Recorded complications and mortality
Complications were identified retrospectively from records through the index day. The form presented separate early- and late-complication items with prelisted event types. No seven-day boundary was communicated to respondents. These questionnaire categories were retained in the analysis; individual event dates were unavailable, so classification as occurring within or after seven days cannot be verified. Recorded early-item events were hemorrhage, subcutaneous emphysema and hypoxia/desaturation; late-item events were granuloma, stoma infection and tracheoesophageal fistula. Observation periods were unequal and unmeasured; these are recorded category counts rather than standardized procedure-anchored incidence estimates.
Recorded in-hospital deaths between 8 September and 8 October 2025 were ascertained from local records and the hospital information system. This is 30-day post-index in-hospital mortality, not mortality within 30 days of tracheostomy or ICU admission. A zero mortality code denotes no recorded in-hospital death; it does not establish survival or continued hospitalization at follow-up. Individual calendar death dates and discharge/transfer histories were unavailable in the retained analysis data. Tracheostomy-to-death intervals are summarized only among patients with a recorded death; comparable procedure-to-censoring intervals are unavailable for the others.
Descriptive analyses
The analyses report counts and percentages with explicit denominators and medians with interquartile ranges and ranges. Patient-level summaries use the 42 current-admission patients. Reason-group outcome counts and admission APACHE II summaries by recorded in-hospital death status are exploratory and were not prospectively specified. Technique is described as a procedural characteristic; outcomes are not compared by technique. No hypothesis tests, adjusted comparisons, causal effects, equivalence claims or survival analyses are presented. Earlier ROC/cutoff and early-versus-late timing analyses are not retained.
Registration chronology
Data collection was completed on 8 October 2025. The initial registry submission was on 5 February 2026 and first posting on 11 February 2026. That entry described 30 tracheostomy patients in seven ICUs and mortality within 30 days after tracheostomy as its only structured outcome. An amendment submitted on 16 June 2026 and posted on 22 June 2026 changed enrollment to the 282-patient census, described eleven ICUs and the 46-patient tracheostomy subgroup, changed the mortality anchor to the index date, and added structured outcomes. The change from 30 to 282 also changed the population represented by the enrollment field, from a tracheostomy subgroup to the full ICU census.
The explanation released for PRS review on 19 October 2026 that the discrepancy was solely a registry-entry error was incorrect. The compilation history is clarified above: 16 records collected on the index day were incorporated after the initial 30-record compilation. This amendment also corrects the unsupported seven-day complication definition and distinguishes form submitters from clinical information sources. These retrospective entries and amendments do not establish prospective specification of the analyses. Historical versions and their dates remain part of the record.
- Conditions
- Tracheostomy
- Being tested
- Tracheostomy
- Keywords
- Tracheostomy, Intensive care unit, Mechanical ventilation, Multidisciplinary decision-making, Point-prevalence study
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
TracheostomyProcedure or surgery
The application of surgical or percutaneous dilatational tracheostomy (Griggs guidewire dilating forceps or Ciaglia single-dilator techniques) for indications such as prolonged mechanical ventilation
| Study group | Role | What they receive |
|---|---|---|
| Tracheostomy Patients | Adults aged 18 years or older with an established surgical or percutaneous tracheostomy who were present in a participating ICU on 8 September 2025. This group comprised 46 of the 282 adults in the census. The revised main descriptive analyses include 42 patients with tracheostomy established during the current admission; four with tracheostomy created before admission contribute only to prevalence and exclusion accounting. Tracheostomy was provided as clinical care and was not assigned by investigators. Receives: Procedure: Tracheostomy |
What is being measured
The primary outcome is the main question the study is designed to answer.
Recorded 30-day post-index in-hospital mortality
Proportion of the 42 current-admission tracheostomy patients with a recorded in-hospital death during the 30 days after the index-day census. Status was assessed by local investigators from records and the hospital information system on 8 October 2025. The time origin is 8 September 2025, not tracheostomy or ICU admission. Individual calendar death dates and discharge/transfer histories were unavailable in the available analysis dataset. The current 42-patient denominator was adopted during manuscript revision after study completion; exploratory reason-group summaries do not establish causal effects.
Measured: From the index date, 8 September 2025, to the follow-up assessment on 8 October 2025 (30 days)
Point-prevalence of tracheostomy and physician-reported reasons for postponement
Prevalence is the number with any established tracheostomy (46) divided by the full adult ICU census (282) on the index day. Reason distributions use the 42 current-admission tracheostomy patients. Primary treating physicians reported family-related reasons, hemodynamic instability, awaiting surgical eligibility or bleeding diathesis. Each patient had at most one reason reported; multiple reasons would have been recorded if reported. No reported reason does not demonstrate absence of postponement. These categories do not measure days attributable to family decisions or establish preventability. The 42-patient restriction and revised descriptive presentation were adopted after study completion.
Measured: Index-day census on 8 September 2025; preceding postponement reasons obtained retrospectively from treating physicians
Secondary outcomes (5)
Total intubation-to-tracheostomy interval (days)
Median and interquartile range of the total number of days between endotracheal intubation and tracheostomy among the 42 current-admission patients, overall and descriptively by recorded physician-reported reason category. The initial recommendation, intended procedure, clinical readiness and family discussion/agreement dates were unavailable. The measured interval is not decision-to-procedure time and cannot quantify days caused by a reported reason. The revised presentation is descriptive; no early-versus-late threshold comparison or timing-effect inference is retained.
Measured: From endotracheal intubation to tracheostomy, retrospectively assessed through 8 September 2025
Distribution of tracheostomy techniques
Numbers and percentages of surgical and percutaneous tracheostomies among the 42 patients with a tracheostomy established during the current admission. Percutaneous procedures are described as Griggs guidewire dilating forceps or Ciaglia single-dilator procedures. Technique was selected in clinical care, not assigned by investigators. This outcome describes procedural distribution, not comparative effectiveness or safety.
Measured: Tracheostomies established before and present on the index day, 8 September 2025
Recorded early and late tracheostomy complications
Numbers and percentages of the 42 current-admission patients with recorded complications, overall and descriptively by recorded reason group. The form presented separate early- and late-complication items with prelisted event types; no seven-day boundary was communicated to respondents. Recorded early-item events were hemorrhage, subcutaneous emphysema and hypoxia/desaturation; late-item events were granuloma, stoma infection and tracheoesophageal fistula. These questionnaire categories were retained in the analysis. Individual event dates were unavailable, so classification as occurring within or after seven days cannot be verified. A patient is counted once in each applicable composite; component categories may overlap. Records were reviewed only through the index day, with unequal and unmeasured observation periods. These counts are not standardized procedure-anchored incidence rates. Reason-group summaries are exploratory; outcomes are not compared by technique.
Measured: From each patient's tracheostomy through the index day, 8 September 2025; observation duration varied between patients
APACHE II score and its discrimination for 30-day mortality
Post-completion amendment during manuscript revision: the June 2026 registry entry specified admission APACHE II discrimination for mortality using the ROC area. An exploratory ROC analysis and a data-derived cutoff appeared in an earlier manuscript version. These analyses are not retained in the revised manuscript because the small selected prevalence sample does not support a validated prediction threshold or confirmatory prognostic interpretation. Current reporting is limited to the median and interquartile range of admission APACHE II scores by recorded in-hospital death status among the 42 current-admission patients. No ROC/AUC result, optimal cutoff, hypothesis test or independent-predictor claim is made in the revised analysis. This existing entry is retained to make the change transparent; it does not represent a prospectively specified descriptive analysis.
Measured: APACHE II assessed once at ICU admission; recorded in-hospital deaths assessed from 8 September to 8 October 2025 (30 days after the index date)
Causes of death among non-survivors
Distribution of causes of death among non-survivors.
Measured: Up to 30 days after the index day
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted11 Feb 2026
- Study start8 Sep 2025
- Primary completion8 Oct 2025
- Study completion8 Oct 2025
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for TracheostomyStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Cohort
- Time perspective
- Cross-sectional
- Enrolment
- 282 participants (actual)
- Target duration
- 30 Days
Sponsor and investigators
- Lead sponsor
- Izmir City Hospital
- Sponsor type
- Other government
- Responsible party
- Principal investigator, Murat Kaykaç, Izmir City Hospital
- Investigators
- Murat KAYKAC, M.D., Study director, Izmir City Hospital
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07404592
- Sponsor's protocol ID
- 2025/352
- Acronym
- IZ-TRACH
- Status last verified
- Oct 2026
- First submitted
- 5 Feb 2026
- Last updated
- 22 Oct 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 22 Oct 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Tracheostomy Practices in Adult Intensive Care Units in Izmir, Turkey: A Multicenter Point-Prevalence Study
- ClinicalTrials.gov ID
- NCT07404592
- Acronym / sponsor ID
- IZ-TRACH / 2025/352
- Conditions
- Tracheostomy
- Keywords
- Tracheostomy, Intensive care unit, Mechanical ventilation, Multidisciplinary decision-making, Point-prevalence study
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 282 participants (actual)
- Lead sponsor
- Izmir City HospitalOther government
- Study start
- 8 Sep 2025 (actual)
- Primary completion
- 8 Oct 2025 (actual)
- Study completion
- 8 Oct 2025 (actual)
- First posted
- 11 Feb 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This completed observational study describes physician-reported reasons for postponement among adults with an established tracheostomy who were present in participating intensive care units (ICUs) on a single survey day. The survey was conducted in eleven adult ICUs in six hospitals in Izmir, Turkey, on 8 September 2025. The census comprised 282 adults; 46 had a tracheostomy. All 46 contribute to the prevalence numerator. The main descriptive sample comprises 42 patients whose tracheostomy was established during the current admission; four patients with tracheostomies created before admission are excluded from patient-level clinical and outcome summaries. Previous clinical and procedural information was collected retrospectively, and postponement reasons were obtained from primary treating physicians. Mortality was assessed 30 days after the index day, on 8 October 2025. Analyses describe reason categories, total intubation-to-tracheostomy intervals, patient and procedural characteristics, recorded complications, and post-index in-hospital mortality. They cannot establish the duration attributable to family decision-making, preventability of postponement, or effects on outcomes. Registration and this clarification occurred after study completion; no prospective specification of the revised analyses is claimed.
Detailed description
Design and populations
This was a multicenter point-prevalence survey on 8 September 2025 with a subsequent assessment of recorded in-hospital mortality on 8 October 2025. The census included 282 adults present in eleven participating ICUs across six hospitals. Forty-six had an established tracheostomy and contribute to the point-prevalence numerator. The main descriptive sample comprises 42 patients whose tracheostomy was established during the current admission. Four with pre-admission tracheostomies remain in the census and prevalence counts but are excluded from the main patient-level summaries. Patients who died or left the ICU before the index day and patients who had not undergone tracheostomy by that date are absent from this sample.
Data collection and compilation
The initial compilation contained 30 tracheostomy patients from seven ICUs. Records for another 16 patients from four additional ICUs within one participating hospital were subsequently incorporated, yielding 46 tracheostomy patients across eleven ICUs. Their postponement reports were obtained on the same index day, 8 September 2025; the records were merged later. Of these 16 patients, three had pre-admission tracheostomies. The remaining 13 contributed to the main analysis, and four had a family-related reason.
Six hospital contact physicians submitted the online forms using information from eleven primary treating physicians, one for each ICU. At the hospital comprising six ICUs, the contact physician collated information from all six primary physicians, including the contact physician's own ICU. Each of the other five hospitals contributed one ICU. Participation in the original tracheostomy decision was not recorded, and reports may have concerned decisions made by colleagues.
Physician-reported reasons and intervals
The index-day form asked: "Please specify any factors that caused tracheostomy to be performed late." Examples included high-dose inotropic support and lack of consent from relatives. This wording assumed lateness and may have influenced responses. Fourteen patients had an explicit "No documented delay" response; none of the 42 responses was blank. These patients are described as having no reported postponement reason, which does not independently establish absence of postponement. Other recorded categories were a family-related reason, hemodynamic instability, awaiting surgical eligibility and bleeding diathesis. Multiple reasons and an "Other" free-text option were allowed; neither was used. Investigators did not select a predominant reason from multiple responses.
A family-related reason represents the physician's account of deliberation or agreement involving relatives or a surrogate decision-maker, not a demonstrated avoidable delay. The measured interval is total time from intubation to tracheostomy. Intended procedure dates, recommendation dates, discussion/agreement dates and clinical readiness dates were unavailable, so time attributable to an individual reason cannot be calculated.
Recorded complications and mortality
Complications were identified retrospectively from records through the index day. The form presented separate early- and late-complication items with prelisted event types. No seven-day boundary was communicated to respondents. These questionnaire categories were retained in the analysis; individual event dates were unavailable, so classification as occurring within or after seven days cannot be verified. Recorded early-item events were hemorrhage, subcutaneous emphysema and hypoxia/desaturation; late-item events were granuloma, stoma infection and tracheoesophageal fistula. Observation periods were unequal and unmeasured; these are recorded category counts rather than standardized procedure-anchored incidence estimates.
Recorded in-hospital deaths between 8 September and 8 October 2025 were ascertained from local records and the hospital information system. This is 30-day post-index in-hospital mortality, not mortality within 30 days of tracheostomy or ICU admission. A zero mortality code denotes no recorded in-hospital death; it does not establish survival or continued hospitalization at follow-up. Individual calendar death dates and discharge/transfer histories were unavailable in the retained analysis data. Tracheostomy-to-death intervals are summarized only among patients with a recorded death; comparable procedure-to-censoring intervals are unavailable for the others.
Descriptive analyses
The analyses report counts and percentages with explicit denominators and medians with interquartile ranges and ranges. Patient-level summaries use the 42 current-admission patients. Reason-group outcome counts and admission APACHE II summaries by recorded in-hospital death status are exploratory and were not prospectively specified. Technique is described as a procedural characteristic; outcomes are not compared by technique. No hypothesis tests, adjusted comparisons, causal effects, equivalence claims or survival analyses are presented. Earlier ROC/cutoff and early-versus-late timing analyses are not retained.
Registration chronology
Data collection was completed on 8 October 2025. The initial registry submission was on 5 February 2026 and first posting on 11 February 2026. That entry described 30 tracheostomy patients in seven ICUs and mortality within 30 days after tracheostomy as its only structured outcome. An amendment submitted on 16 June 2026 and posted on 22 June 2026 changed enrollment to the 282-patient census, described eleven ICUs and the 46-patient tracheostomy subgroup, changed the mortality anchor to the index date, and added structured outcomes. The change from 30 to 282 also changed the population represented by the enrollment field, from a tracheostomy subgroup to the full ICU census.
The explanation released for PRS review on 19 October 2026 that the discrepancy was solely a registry-entry error was incorrect. The compilation history is clarified above: 16 records collected on the index day were incorporated after the initial 30-record compilation. This amendment also corrects the unsupported seven-day complication definition and distinguishes form submitters from clinical information sources. These retrospective entries and amendments do not establish prospective specification of the analyses. Historical versions and their dates remain part of the record.
Study design
- Observational model
- Cohort
- Time perspective
- Cross-sectional
- Target follow-up
- 30 Days
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Tracheostomy Patients | – | Procedure: TracheostomyAdults aged 18 years or older with an established surgical or percutaneous tracheostomy who were present in a participating ICU on 8 September 2025. This group comprised 46 of the 282 adults in the census. The revised main descriptive analyses include 42 patients with tracheostomy established during the current admission; four with tracheostomy created before admission contribute only to prevalence and exclusion accounting. Tracheostomy was provided as clinical care and was not assigned by investigators. |
Who may qualify
- Ages
- 18 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Adult, Older adult
- Study population
- Adults aged 18 years or older present in eleven participating adult ICUs across six hospitals in Izmir, Turkey, on 8 September 2025 formed the 282-person census. Forty-six had a surgical or percutaneous tracheostomy and contribute to overall prevalence. The main descriptive sample includes the 42 whose tracheostomy was established during the current admission. Four with tracheostomies created before admission are included only in census/prevalence counts and exclusion accounting. This revision of the analysis population does not change the census eligibility criteria or actual enrollment of 282.
Key inclusion criteria (2 listed)
- Aged 18 years and older
- Present in a participating adult ICU on the point-prevalence day
Key exclusion criteria (1 listed)
- Patients younger than 18 years
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| TracheostomyThe application of surgical or percutaneous dilatational tracheostomy (Griggs guidewire dilating forceps or Ciaglia single-dilator techniques) for indications such as prolonged mechanical ventilation | Procedure or surgery | Tracheostomy Patients |
Primary outcome
Recorded 30-day post-index in-hospital mortality
Time frame: From the index date, 8 September 2025, to the follow-up assessment on 8 October 2025 (30 days)
Proportion of the 42 current-admission tracheostomy patients with a recorded in-hospital death during the 30 days after the index-day census. Status was assessed by local investigators from records and the hospital information system on 8 October 2025. The time origin is 8 September 2025, not tracheostomy or ICU admission. Individual calendar death dates and discharge/transfer histories were unavailable in the available analysis dataset. The current 42-patient denominator was adopted during manuscript revision after study completion; exploratory reason-group summaries do not establish causal effects.
Point-prevalence of tracheostomy and physician-reported reasons for postponement
Time frame: Index-day census on 8 September 2025; preceding postponement reasons obtained retrospectively from treating physicians
Prevalence is the number with any established tracheostomy (46) divided by the full adult ICU census (282) on the index day. Reason distributions use the 42 current-admission tracheostomy patients. Primary treating physicians reported family-related reasons, hemodynamic instability, awaiting surgical eligibility or bleeding diathesis. Each patient had at most one reason reported; multiple reasons would have been recorded if reported. No reported reason does not demonstrate absence of postponement. These categories do not measure days attributable to family decisions or establish preventability. The 42-patient restriction and revised descriptive presentation were adopted after study completion.
5 secondary outcomes
Total intubation-to-tracheostomy interval (days)
Time frame: From endotracheal intubation to tracheostomy, retrospectively assessed through 8 September 2025
Distribution of tracheostomy techniques
Time frame: Tracheostomies established before and present on the index day, 8 September 2025
Recorded early and late tracheostomy complications
Time frame: From each patient's tracheostomy through the index day, 8 September 2025; observation duration varied between patients
APACHE II score and its discrimination for 30-day mortality
Time frame: APACHE II assessed once at ICU admission; recorded in-hospital deaths assessed from 8 September to 8 October 2025 (30 days after the index date)
Causes of death among non-survivors
Time frame: Up to 30 days after the index day
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 22 Oct 2026.
Related trials for Tracheostomy
Not yet recruitingObservational study
A Speaking-Valve-Based Decannulation Protocol for Tracheostomized Stroke Patients
Stroke Patients, Tracheostomy
Enrolling by invitationObservational study
A Speaking-Valve-Based Decannulation Protoco for Patients With a Prolonged Disorders of Consciousness
Prolonged Disorders of Consciousness, Tracheostomy
Not yet recruitingObservational study
Laryngotracheal Lesions in Adults With Long-Term Tracheostomy
Laryngotracheal Lesions, Tracheostomy Complications
Enrolling by invitation
No DIET Trial: Dogmatic Interruption of Enteral nuTrition
Gastrostomy, Tracheostomy
Recruiting
Classical Music, Pain, and Physiological Parameters in Children Undergoing Two Aspiration Procedures
Endotracheal Aspiration, Tracheostomy Patients
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Murat KAYKAC, M.D. study director
Izmir City Hospital
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Tracheostomy, run by Izmir City Hospital at 1 site in Turkey (Türkiye).
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 22 Oct 2026. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Recorded 30-day post-index in-hospital mortality (time frame: From the index date, 8 September 2025, to the follow-up assessment on 8 October 2025 (30 days)). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Oct 2026.